Oncolytic Virotherapy and Immunogenic Cell Death: Mechanisms, Platforms, and Clinical Translation.

Median overall survival showed a trend toward improvement at 23.3 months versus 18.9 months, although this difference did not achieve statistical significance in the primary analysis [ 20 , 117 ].

also in 53,322 other papers